Back to search

Integrative Genomics Identifies Distinct Molecular Classes of Neuroblastoma and Shows That Multiple Genes Are Targeted by Regional Alterations in DNA Copy Number

Data up to Jan 2025

Published2006
Citations203
References77

Total Citations Per Year

Abstract

References (77)

Gene Ontology: tool for the unification of biology

2000 • 38,297 citations

Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring

1999 • 11,586 citations

In silico prediction of protein-protein interactions in human macrophages

2014 • 11,120 citations

Significance analysis of microarrays applied to the ionizing radiation response

2001 • 10,393 citations

The Human Genome Browser at UCSC

2002 • 9,920 citations

The Protein Kinase Complement of the Human Genome

2002 • 7,708 citations

DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

2005 • 2,633 citations

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

2001 • 2,626 citations

Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease Stage

1984 • 2,248 citations

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1993 • 2,242 citations

Neuroblastoma: biological insights into a clinical enigma

2003 • 2,087 citations

Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas

1985 • 1,989 citations

Identifying biological themes within lists of genes with EASE

2003 • 1,969 citations

Treatment of High-Risk Neuroblastoma with Intensive Chemotherapy, Radiotherapy, Autologous Bone Marrow Transplantation, and 13-cis-Retinoic Acid

1999 • 1,843 citations

Senescence in premalignant tumours

2005 • 1,394 citations

Germ-Line Mutations in Nonsyndromic Pheochromocytoma

2002 • 1,342 citations

The International Neuroblastoma Pathology Classification (the Shimada system)

1999 • 966 citations

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

2000 • 799 citations

Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death

2004 • 703 citations

Molecular Biology of Neuroblastoma

1999 • 644 citations

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.

1991 • 595 citations

Chromosome 1p and 11q Deletions and Outcome in Neuroblastoma

2005 • 546 citations

Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma

1999 • 543 citations

Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors

2005 • 448 citations

TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

2001 • 438 citations

Alterations of the PPP2R1B Gene in Human Lung and Colon Cancer

1998 • 358 citations

Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma

2005 • 326 citations

Statistical estimation of prognosis for children with neuroblastoma.

1971 • 321 citations

International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors

2001 • 277 citations

Analysis of chromosome breakpoints in neuroblastoma at sub‐kilobase resolution using fine‐tiling oligonucleotide array CGH

2005 • 273 citations

Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas

1999 • 250 citations

Biologic Factors Determine Prognosis in Infants With Stage IV Neuroblastoma: A Prospective Children’s Cancer Group Study

2000 • 238 citations

PPM1D is a potential target for 17q gain in neuroblastoma.

2003 • 228 citations

A Molecular Classification of Papillary Renal Cell Carcinoma

2005 • 226 citations

CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas

2005 • 204 citations

The biologic basis for neuroblastoma heterogeneity and risk stratification

2005 • 197 citations

Allelic Losses at 1p36 and 19q13 in Gliomas: Correlation with Histologic Classification, Definition of a 150-kb Minimal Deleted Region on 1p36, and Evaluation of CAMTA1 as a Candidate Tumor Suppressor Gene

2005 • 183 citations

Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma

2005 • 181 citations

Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with Neuroblastoma

2004 • 178 citations

Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma

2004 • 166 citations

CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system

2003 • 164 citations

Loss of Heterozygosity at 1p36 Independently Predicts for Disease Progression But Not Decreased Overall Survival Probability in Neuroblastoma Patients: A Children’s Cancer Group Study

2000 • 161 citations

RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis.

1998 • 148 citations

Alterations in the PITSLRE protein kinase gene complex on chromosome 1p36 in childhood neuroblastoma

1994 • 116 citations

Gene Expression of Parathyroid Tumors

2004 • 109 citations

Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma.

2003 • 109 citations

Opsoclonus‐myoclonus‐ataxia syndrome in neuroblastoma: Histopathologic features–A report from the children's cancer group†

2001 • 107 citations

Generation of patterns from gene expression data by assigning confidence to differentially expressed genes

2000 • 98 citations

High‐resolution detection and mapping of genomic DNA alterations in neuroblastoma

2005 • 98 citations

Detection of MYCN Gene Amplification in Neuroblastoma by Fluorescence In Situ Hybridization: A Pediatric Oncology Group Study

2001 • 90 citations

Association of Epigenetic Inactivation of RASSF1A with Poor Outcome in Human Neuroblastoma

2004 • 87 citations

Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.

2002 • 87 citations

Inhibition of a New Differentiation Pathway in Neuroblastoma by Copy Number Defects of N-myc, Cdc42, and nm23 Genes

2005 • 83 citations

Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma.

2003 • 77 citations

Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors

2005 • 74 citations

Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q

2004 • 67 citations

Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

2003 • 67 citations

Coordinate Deletion of Chromosome 3p and 11q in Neuroblastoma Detected by Comparative Genomic Hybridization

2000 • 66 citations

Methylation-Associated Silencing of theNuclear Receptor 1I2Gene in Advanced-Type Neuroblastomas, Identified by Bacterial Artificial Chromosome Array-Based Methylated CpG Island Amplification

2005 • 63 citations

Gene expression profiling of 1p35–36 genes in neuroblastoma

2004 • 62 citations

Coupled analysis of gene expression and chromosomal location

2005 • 54 citations

Abnormal constitutional karyotypes in patients with neuroblastoma: a report of four new cases and review of 47 others in the literature

2003 • 47 citations

Caspase-9 and Apaf-1 are expressed and functionally active in human neuroblastoma tumor cell lines with 1p36 LOH and amplified MYCN

2002 • 46 citations

Inferring a Tumor Progression Model for Neuroblastoma From Genomic Data

2005 • 42 citations

Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma

2003 • 41 citations

A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.

2005 • 40 citations

Gene Profiling of High Risk Neuroblastoma

2005 • 39 citations

Expression Level of Neural Cell Adhesion Molecule (NCAM) Inversely Correlates with the Ability of Neuroblastoma Cells to Adhere to Endothelium In Vitro

2002 • 37 citations

High-Resolution Mapping of a 130-kb Core Region of theMYCNAmplicon in Neuroblastomas

1996 • 37 citations

Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology

2005 • 35 citations

ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas.

2003 • 29 citations

Detection of Single-Copy Chromosome 17q Gain in Human Neuroblastomas Using Real-Time Quantitative Polymerase Chain Reaction

2003 • 28 citations

MYCN Is the only highly expressed gene from the core amplified domain in human neuroblastomas

1998 • 23 citations

A review of DNA microarray analysis of human neuroblastomas

2005 • 21 citations

Prognostic value of MYCN and ID2 overexpression in neuroblastoma

2005 • 21 citations

Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11

2005 • 20 citations

No evidence for involvement of SDHD in neuroblastoma pathogenesis

2004 • 17 citations

Cited By (0)

No citing papers found in database

Integrative Genomics Identifies Distinct Molecular Classes of Neuroblastoma and Shows… (2006) – Cancer Research | Metascience Observatory Explorer